In this Editorial Article, experts Dr. Andy Herbert, Co-Founder and CTO, and Dr. Elizabeth Blackburn, Principal Scientist at Invizius, share how their research contributes to tackling biocompatibility challenges in extracorporeal systems and how immunoassays play a critical role in generating reproducible and robust data.
Regulatory bodies worldwide increasingly recognize the importance of complement measurement in ensuring the safety and efficacy of medical devices.